<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1705222038
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2010
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DEXTROSE 5% & RINGER LACTATE INFUSION SOLUTION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DEXTROSE,SODIUM CHLORIDE,POTASSIUM CHLORIDE, CALCIUM CHLORIDE,SODIUM LACTATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        55,6,0.4,0.27,3.20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        g/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        1000
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        11.1
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Pharmaceutical Solution Industries (PSI)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Pharmaceutical Solution Industries (PSI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 444]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Pharmaceutical Solution Industries (PSI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Pharmaceutical Solution Industries (PSI)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05BA03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion is used: as a source<br />of carbohydrate (sugar) in the following situations:<br />- To treat a loss of body water and chemicals (e.g. by heavy sweating, kidney disorders) to<br />treat you, if the volume of blood in your blood vessels is low (hypovolaemia) or if you have<br />low blood pressure (hypotension).<br />- In metabolic acidosis (when the blood becomes too acidic).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not receive 5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion if you<br />are suffering from any of the following conditions<br />- If you&rsquo;re a newborn (less than 28 days old) receiving ceftriaxone (an antibiotic).<br />- If you&rsquo;re allergic to sodium lactate or any of the other substances in Compound Sodium<br />Lactate/Dextrose Infusion<br />- When there is too much fluid in the spaces around the cells of the body (extracellular hyperhydration)<br />- When there is a larger volume of blood in the blood vessels than there should be (hypervolaemia)<br />- Severe kidney failure (when your kidneys do not work well and you require dialysis)<br />- Uncompensated heart failure. This is heart failure that is not adequately treated and<br />causes symptoms such as:<br />- Shortness of breath<br />- swelling of the ankles.<br />- Higher levels of potassium in the blood than normal (hyperkalaemia)<br />- Higher levels of calcium in the blood than normal (hypercalcaemia)<br />- A disorder in which the blood becomes too alkaline (metabolic alkalosis)<br />- Liver disease that causes fluid to build up within the abdomen (ascitic cirrhosis)<br />- Your blood is too acidic which is life-threatening (severe metabolic acidosis) - a particular<br />type of metabolic acidosis (lactic acidosis)<br />- Severe liver disease (when the liver does notfunction properly and requires very intensive treatment)<br />- Poor lactate metabolism (this occurs in severe liver disease, as lactate is removed by the liver)<br />- If you are taking cardiac glycosides (cardiotonics) used to treat heart failure, such as<br />digitalis or digoxin (See also &ldquo;Taking other medicines&rdquo;)<br />- Diabetes that is not adequately treated, allowing your blood sugar levels to rise above<br />normal (uncompensated diabetes) - states of Dextrose intolerance, for example: -<br />metabolic stress (when the body&rsquo;s metabolism does not function correctly, e.g. due to<br />severe illness) - hyperosmolar coma (unconsciousness). This is a type of coma that can<br />occur if you have diabetes and do not receive enough medicine. - a higher amount of sugar<br />in the blood than normal (hyperglycaemia) &ndash; a higher amount of lactate in the blood than<br />normal (hyperlactataemia)<br />Warning and precautions<br />5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion is a hypertonic<br />(concentrated) solution. Your doctor will take this into account when calculating how much<br />solution to give you.<br />Talk to your doctor or nurse before receiving 5% Dextrose w/v in Compound Sodium<br />Lactate Solution for Infusion if you have or have had any of the following medical<br />conditions.<br />- If you&rsquo;re receiving ceftriaxone (an antibiotic).(See also &ldquo;Other medicines and 5% Dextrose<br />w/v in Compound Sodium Lactate Solution for Infusion&rdquo;)<br />- Heart failure<br />- Respiratory failure (lung disease) (special monitoring may be required in the above<br />conditions)<br />- Poor kidney function - higher levels of chloride in the blood than normal (hyperchloraemia)<br />- high blood pressure (hypertension)<br />- Buildup of fluid under the skin, affecting all parts of the body (general oedema)<br />- Buildup of fluid under the skin, particularly around the ankles (peripheral oedema)<br />- Buildup of fluid in the lungs (pulmonary oedema)<br />- High blood pressure during pregnancy (pre-eclampsia)<br />- a disease that causes high levels of a hormone called aldosterone (aldosteronism) -<br />higher levels of sodium in the blood than normal (hypernatraemia) or any other condition<br />associated with sodium retention (when the body retains too much sodium), such as<br />treatment with steroids (See also below, &ldquo;Taking other medicines&rdquo;).<br />- Diabetes (your blood sugar levels will be monitored closely and your insulin treatment<br />may need to be modified)<br />- Heart disease of any type<br />- Any condition that means that you are more likely to have high blood levels of potassium<br />(hyperkalaemia), such as:<br />- Kidney failure<br />- Adrenocortical insufficiency (this disease of the adrenal gland affects hormones that<br />control the concentration of chemicals in the body)<br />- Acute dehydration (a loss of water from the body, e.g. due to vomiting or diarrhoea)<br />- Extensive tissue damage (as can occur in severe burns) close monitoring of your blood<br />potassium levels is required.<br />- Diseases associated with high levels of vitamin D (e.g. sarcoidosis, a disease affecting<br />the skin and internal organs)<br />- Kidney stones</p><p>Poor liver function<br />- A high pressure within the skull (intracranial hypertension)<br />- A stroke due to a clot in a blood vessel in the brain (ischaemic stroke)<br />- If you had a head injury less than a day ago.<br />When you are given this infusion, your doctor will take blood and urine samples to monitor:<br />- The amount of chemicals such as sodium and potassium in your blood (your plasma electrolytes)<br />- The amount of sugar (Dextrose)<br />- The acidity of your blood and urine (your acid-base balance).<br />Although Compound Sodium Lactate/Dextrose Infusion contains potassium, it does not contain<br />enough to treat very low blood plasma levels of potassium (severe potassium deficiency).<br />Calcium chloride can be harmful if injected into the body tissues. Therefore, the 5%<br />Dextrose w/v in Compound Sodium Lactate Solution for Infusion must not be given by<br />injecting it into a muscle (intramuscular injection). Also, your doctor will make every effort to<br />avoid the escape of the solution into the tissues surrounding the vein.<br />5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion must not be given<br />through the same needle as a blood transfusion. This can damage the red blood cells or<br />cause them to clump together.<br />As 5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion contains lactate (a<br />substance found in the body), it can make your blood too alkaline (metabolic alkalosis).<br />As 5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion contains sugar<br />(Dextrose), it can cause a high level of sugar in the blood (hyperglycaemia). If this occurs,<br />your doctor may:<br />- adjust the speed of infusion<br />- give you insulin to reduce the blood sugar levels<br />This is particularly important if you are diabetic.<br />Children<br />5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion should be given with<br />special care in children. Newborns, especially those born premature and with low birth<br />weight, are at increased risk of developing low or high levels of sugar in the blood (hypo-or<br />hyperglycemia), which may lead to complications.<br />Your doctor will take into account if you are receiving parenteral nutrition (nutrition given by<br />infusion into a vein). If you are given Compound Sodium Lactate/Dextrose Infusion for a<br />long time, you will be given an extra source of nutrients<br />Other medicines and 5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion<br />Please tell your doctor or nurse if you are taking, have recently taken or might have taken<br />any other medicines.<br />It is particularly important that you inform your doctor if you are taking:<br />- Ceftriaxone (an antibiotic), this should not be given through the same infusion line, unless<br />thoroughly flushed.<br />- Cardiac glycosides (cardiotonics) such as digitalis or digoxin, used to treat heart failure,<br />must not be used with 5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion<br />(see also section &ldquo;You must NOT receive 5% Dextrose w/v in Compound Sodium Lactate<br />Solution for Infusion if you are suffering from &hellip;&rdquo;). The effects of these drugs can be<br />increased by calcium. This can lead to life threatening changes to the heart rhythm<br />- Corticosteroids (anti-inflammatory medicines)<br />These medicines can cause the body to accumulate sodium and water, leading to:<br />- Tissue swelling due to fluid collection under the skin (oedema) - high blood pressure (hypertension).<br />The following medicines can increase the concentration of potassium in the blood. This<br />effect can be life threatening.</p><p>A rise in the blood potassium levels is more likely to occur if you have kidney disease.<br />- Potassium-sparing diuretics (certain water tablets, e.g. amiloride, spironolactone,<br />triamterene) (Note that these medicines may be included in combination medicinal products)<br />- Angiotensin converting enzyme (ACE) inhibitors (used to treat high blood pressure)<br />- Angiotensin II receptor antagonists (used to treat high blood pressure)<br />- Tacrolimus (used to prevent rejection of a transplant and to treat some skin diseases)<br />- Cyclosporin (used to prevent rejection of a transplant)<br />Other medicines that can affect or be affected by 5% Dextrose w/v in Compound Sodium<br />Lactate Solution for Infusion include:<br />- Thiazide diuretics such as hydrochlorothiazide or chlortalidone<br />- Vitamin D.<br />- Bisphosphonates (to treat bone diseases such as osteoporosis)<br />- fluoride (for the teeth and bones)<br />- Fluoroquinolones (a type of antibiotic, including ciprofloxacin, norfloxacin, ofloxacin)<br />- Tetracyclines (a type of antibiotic, including tetracycline)<br />- Acidic medicines, including:<br />- Salicylates used to treat inflammation (aspririn)<br />- Barbiturates (sleeping tablets)<br />- Lithium (used to treat psychiatric illness)<br />- Alkaline (basic) medicines including:<br />- Sympathomimetics (stimulant medicines such as ephedrine and pseudoephedrine, used<br />in cough and cold preparations).<br />- Other stimulants (e.g. dexamphetamine, phenfluramine).<br />5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion with food and drink<br />You should ask your doctor or nurse about what you can eat or drink.<br />Pregnancy and breast-feeding<br />If you are pregnant of breast feeding, think you may be pregnant or are planning to have a<br />baby ask your doctor or nurse for advice before taking this medicine. 5% Dextrose w/v in<br />Compound Sodium Lactate Solution for Infusion can be used safely during pregnancy or<br />breast-feeding.<br />Your doctor will monitor the levels of chemicals in your blood and the amount of fluid in<br />your body.<br />Calcium can reach your unborn baby through the placenta and, after birth, through the<br />breast milk.<br />However, if another medicine is to be added to your solution for infusion during pregnancy<br />or breast-feeding you should:<br />- consult your doctor or nurse.<br />- read the Package Leaflet of the medicine that is to be added.<br />Driving and using machines<br />Ask your doctor or pharmacist for advice before driving or using machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You will be given 5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion by a<br />doctor or nurse.<br />Your doctor will decide on how much you need and when it is to be given. This will depend<br />on your age, weight, condition and the reason for treatment. The amount you are given</p><p>may also be affected by other treatments you are receiving.<br />You should NOT be given 5% Dextrose w/v in Compound Sodium Lactate Solution for<br />Infusion if there are particles floating in the solution or if the pack is damaged in any way.<br />5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion will usually be given to<br />you through a plastic tube attached to a needle in a vein. Usually a vein in your arm is used to<br />give you the infusion. However, your doctor may use another method to give you the medicine.<br />Any unused solution should be thrown away. You should NOT be given an infusion of 5%<br />Dextrose w/v in Compound Sodium Lactate Solution for Infusion from a bag that has been<br />partly used.<br />If you receive more 5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion<br />than you should<br />If you are given too much 5% Dextrose w/v in Compound Sodium Lactate Solution for<br />Infusion (over-infusion) or it is given too fast, this may lead to the following symptoms:<br />- Water and/or sodium (salt) overload with build-up of liquid in the tissues (oedema)<br />causing swelling<br />- Hyperkalaemia (higher levels of potassium in the blood than normal) especially in patients<br />with kidney failure, causing symptoms such as:<br />- Pins and needles in the arms and legs (paresthesia)<br />- Muscle weakness<br />- An inability to move (paralysis)<br />- An irregular heartbeat (cardiac arrhythmias)<br />- Heart block (a very slow heartbeat)<br />- Cardiac arrest (the heart stops beating; a life-threatening situation)<br />- Confusion<br />&ndash; Hypercalcaemia (higher levels of calcium in the blood than normal) causing symptoms such as:<br />- A decreased appetite (anorexia)<br />- Feeling sick (nausea)<br />- Vomiting<br />- Constipation<br />- Abdominal pain<br />- Mental disturbances such as irritability or depression<br />- Drinking lots of water (polydipsia)<br />- Producing more urine than normal (polyuria)<br />- Kidney disease due to buildup of calcium in the kidneys (nephrocalcinosis)<br />- Kidney stones<br />- Coma (unconsciousness)<br />- Chalky taste<br />- Redness (hot flushes)<br />- Dilatation of the blood vessels in the skin (peripheral vasodilatation).<br />- Hypokalaemia (lower levels of potassium in the blood than normal) and metabolic<br />alkalosis (when the blood becomes too basic) especially in patients with kidney failure,<br />causing symptoms such as:<br />- Mood changes<br />- Tiredness<br />- Shortness of breath<br />- Stiffness of the muscles<br />- Twitching of the muscles<br />- Contraction of muscles.<br />- The blood becomes too concentrated (hyperosmolarity)<br />- A loss of water from the body (dehydration)<br />- A high blood sugar level (hyperglycaemia)<br />- Sugar in the urine (hyperglycosuria)<br />- An increase in the amount of urine you produce (osmotic diuresis)</p><p>If you develop any of these symptoms you must inform your doctor immediately. Your<br />infusion will be stopped and you will be given treatment depending on the symptoms.<br />If a medicine has been added to your % Dextrose w/v in Compound Sodium Lactate<br />Solution for Infusion before over-infusion occurs, that medicine may also cause symptoms.<br />You should read the Package Leaflet of the added medicine for a list of possible symptoms<br />Stopping your % Dextrose w/v in Compound Sodium Lactate Solution for Infusion<br />Your doctor will decide when to stop giving you this infusion. If you have any further<br />questions on the use of this product, ask your doctor or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />If you have any of the following symptoms you should tell your doctor or nurse immediately.<br />These may signs of a very severe or even fatal hypersensitivity (allergic) reaction called<br />anaphylactic shock:<br />- hives (urticaria) which may be localised to a part of the body or widespread<br />- skin rash<br />- redness of the skin (erythema)<br />- Itching (pruritus)<br />- Skin swelling (angioedema)<br />- Narrowing of the airways causing difficulty breathing (bronchospasm)<br />- Chest discomfort or pain<br />- Shortness of breath (dyspnea)<br />- Fever (pyrexia)<br />- Nausea<br />- Coughing<br />Some reactions may be due to the administration technique:<br />- Rash or itching (pruritus) of the infusion site<br />- Local pain or reaction (redness or swelling at the site of infusion)<br />- Infusion site anesthesia (numbness)<br />Other side effects noted with similar products (other sodium-lactate containing solutions)<br />include:<br />Other manifestations of hypersensitivity/infusion reactions: Laryngeal oedema (Quincke&rsquo;s<br />edema), a slow heartbeat (bradycardia),a fast heartbeat (tachycardia), Blood pressure<br />decreased, Respiratory distress, Flushing, Throat irritation, Skin swelling, pins and needles<br />(paresthesias), reduced sense in the mouth (hypoesthesia oral), altered taste (dysgeusia);<br />&bull; Anxiety<br />&bull; Headache,<br />&bull; Nasal congestion,<br />&bull; Sneezing<br />&bull; Changes in the concentrations of the chemicals in the blood (electrolyte disturbances)<br />&bull; Higher levels of potassium in the blood than normal (hyperkalemia)<br />&bull; A larger volume of blood in the blood vessels than there should be (hypervolemia)<br />&bull; Panic Attack<br />&bull; Other infusion site reactions: Infection at the site of injection, Phlebitis, Extravasation,<br />Infusion site inflammation, Infusion site swelling, Infusion site rash, Infusion site pain,</p><p>Infusion site burning<br />If a medicine has been added to the solution for infusion, the added medicine may also cause<br />side effects. These side effects will depend on the medicine that has been added. You should<br />read the Patient Information Leaflet of the added medicine for a list of possible symptoms.<br />Reporting of side effects<br />If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any<br />possible side effects not listed in this leaflet. You can also report side effects directly via the<br />national reporting system listed below. By reporting side effects you can help provide more<br />information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children. Store below 25 Co<br />You should NOT be given this medicine after the expiry date which is stated on the bag (eg<br />EXP: MM/YYYY). The expiry date refers to the last day of that month. You should not be given<br />this medicine, if there are particles floating in the solution or if the unit is damaged in</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What 5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion contains?<br />The active substances are: - sugar (Dextrose)<br />- Sodium chloride<br />- Potassium chloride<br />- Calcium chloride dehydrate.<br />- Sodium lactate<br />The only other ingredient is water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                5% Dextrose w/v in Compound Sodium Lactate Solution for Infusion Solution for Infusion
is a clear solution, free from visible particles.
It is supplied in NPVC plastic bags.
The bag sizes are: 500 ml, 1000 ml.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharmaceutical Solutions Industry Ltd.<br />Industrial Estate, Phase-2,<br />Road No. 208, Str. - 203<br />P O Box 17476<br />Jeddah 21484<br />Western Province<br />Saudi Arabia<br />Phone: +966-12-6361383<br />FAX: +966-12-6379460<br />Website: http://www.psiltd.com<br />This leaflet was revised in May 2021</p><p>To report any side effect(s):</p><p>&bull; Saudi Arabia:<br />The National Pharmacovigilance Centre (NPC):<br />Fax: +966-11-205-7662<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa<br />Other GCC States:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                03.05.2021
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>٥٪ وزن/حجم دكستروز في مركب الصودیوم لاكتیت یستخدم لعلاج فقدان میاه الجسم والمواد الكیمیائیة (مثل التعرق<br />الشدید ، واضطرابات الكلى)<br />&bull; لعلاجك إذا كان حجم الدم في الأوعیة الدمویة منخفضًا (نقص حجم الدم) أو إذا كان لدیك انخفاض في ضغط الدم (انخفاض ضغط الدم)<br />&bull; في الحماض الاستقلابي (عندما یصبح الدم حمضیًا جدًا).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>یجب ألا تتلقى ٥٪ وزن/حجم دكستروز في مركب الصودیوم لاكتیت إذا كنت تعاني من أي من الحالات التالیة:<br />&bull; إذا كنت مولودًا جدیدًا (أقل من ۲۸ یومًا) تتلقى سیفتریاكسون (مضاد حیوي)<br />( &bull; إذا كنت تعاني من حساسیة من لاكتات الصودیوم أو أي من المكونات الأخرى في مركب الصودیوم لاكتات (مدرج في القسم ٦<br />&bull; عندما یكون ھناك الكثیر من السوائل في المساحات المحیطة بخلایا الجسم (فرط الجفاف خارج الخلیة)<br />&bull; عندما یزید حجم الدم في الأوعیة الدمویة اكثر مما یجب<br />&bull; الفشل الكلوي الحاد (عندما لا تعمل كلیتك جیدًا وتحتاج إلى غسیل الكلى)<br />&bull; قصور القلب غیر المكافئ (فشل القلب الذي لا یتم علاجھ بشكل كاف ویسبب أعراضًا مثل: - ضیق التنفس - تورم الكاحلین.)<br />&bull; ارتفاع مستویات البوتاسیوم في الدم عن المعدل الطبیعي (فرط بوتاسیوم الدم)<br />&bull; ارتفاع مستویات الكالسیوم في الدم عن المعدل الطبیعي (فرط كالسیوم الدم)<br />&bull; اضطراب یصبح فیھ الدم قلویًا جدًا (قلاء استقلابي)<br />&bull; مرض الكبد الذي یتسبب في تراكم السوائل داخل البطن (تلیف الكبد الحاد).<br />&bull; دمك شدید الحموضة وھو ما یھدد الحیاة (الحماض الأیضي الحاد)<br />&bull;&bull; نوع معین من الحماض الایضي (الحماض اللبني)<br />&bull; مرض الكبد الحاد (عندما لا یعمل الكبد بشكل صحیح ویتطلب علاجًا مكثفًا للغایة)<br />&bull; ضعف استقلاب اللاكتات (یحدث ھذا في مرض الكبد الحاد ، حیث تتم إزالة اللاكتات بواسطة الكبد)<br />&bull; إذا كنت تتناول الجلیكوسیدات المستخدمة لعلاج قصور القلب ، مثل الدیجیتال أو الدیجوكسین (انظر أیضًا &quot;تناول أدویة أخرى&quot;).<br />&bull; مرض السكري الذي لا یتم علاجھ بشكل كافٍ ، مما یسمح بارتفاع مستویات السكر في الدم عن المعدل الطبیعي<br />(مرض السكري غیر المكافئ)<br />- حالات عدم تحمل دكستروز ، على سبیل المثال: - الإجھاد الأیضي (عندما لا یعمل التمثیل الغذائي في الجسم بشكل<br />صحیح ، على سبیل المثال بسبب مرض شدید) غیبوبة (فاقد الوعي). ھذا نوع من الغیبوبة التي یمكن أن تحدث إذا<br />كنت مصابًا بمرض السكري ولا تتلقى ما یكفي من الأدویة.<br />- نسبة السكر في الدم أعلى من المعتاد (ارتفاع السكر في الدم)<br />- كمیة اللاكتات في الدم أعلى من المعتاد (فرط سكر الدم في الدم)<br />المحاذیر والإحتیاطات<br />ھو محلول مفرط التوتر (مركز). سیأخذ طبیبك ھذا الأمر في الاعتبار عند حساب مقدار المحلول الذي یعطیھ لك.<br />تحدث إلى طبیبك أو ممرضك قبل تلقي مركب كلورید الصودیوم لاكتیت إذا كان لدیك أو عانیت من أي من الحالات<br />الطبیة التالیة:<br />&bull; إذا كنت تتلقى عقار السیفتریاكسون (مضاد حیوي).<br />&bull; فشل القلب.<br />&bull; فشل الجھاز التنفسي (أمراض الرئة) (قد یلزم متابعة خاصة في الحالات المذكورة أعلاه).<br />&bull; ضعف وظائف الكلى.<br />&bull; ارتفاع مستویات الكلورید في الدم عن المعدل الطبیعي (فرط كلور الدم).<br />&bull; ارتفاع ضغط الدم (ارتفاع ضغط الدم).<br />&bull; ترسب السوائل تحت الجلد ، مما یؤثر على جمیع أجزاء الجسم (الوذمة).<br />&bull; ترسب السوائل تحت الجلد ، خاصة حول الكاحلین (الوذمة المحیطیة)<br />&bull; ترسب السوائل في الرئتین (الوذمة الرئویة)<br />&bull; ارتفاع ضغط الدم أثناء الحمل (مقدمات الارتعاج)<br />&bull; مرض یسبب مستویات عالیة من ھرمون یسمى الألدوستیرون (الألدوستیرونیة).<br />&bull; ارتفاع مستویات الصودیوم في الدم عن المعدل الطبیعي (فرط صودیوم الدم) أو أي حالة أخرى مرتبطة بالاحتفاظ بالصودیوم<br />(عندما یحتفظ الجسم بالكثیر من الصودیوم) ، مثل العلاج باستخدام المنشطات (انظر أیضًا أدناه ، &quot;تناول أدویة أخرى&quot;)<br />&bull; مرض السكري (ستتم مراقبة مستویات السكر في الدم عن كثب وقد یلزم تعدیل علاج الأنسولین).<br />&bull;&bull; أمراض القلب من أي نوع<br />&bull; أي حالة تعني زیادة احتمال ارتفاع مستویات البوتاسیوم في الدم (فرط بوتاسیوم الدم) ، مثل<br />- فشل كلوي<br />- قصور في القشرة الكظریة (یؤثر مرض الغدة الكظریة على الھرمونات التي تتحكم في تركیز المواد الكیمیائیة في الجسم)<br />- الجفاف الحاد (فقدان الماء من الجسم ، على سبیل المثال بسبب القيء أو الإسھال).<br />- تلف الأنسجة واسعة النطاق (كما یمكن أن یحدث في الحروق الشدیدة) مطلوب رصد دقیق لمستویات البوتاسیوم في الدم.<br />&bull; الأمراض المرتبطة بمستویات عالیة من فیتامین (د) مثل الساركوید ، وھو مرض یصیب الجلد والأعضاء الداخلیة<br />&bull; حصى الكلى<br />&bull; ضعف وظائف الكبد<br />- ارتفاع الضغط داخل الجمجمة (ارتفاع ضغط الدم داخل الجمجمة)<br />- سكتة دماغیة نتیجة لتجلط في الأوعیة الدمویة في الدماغ (السكتة الدماغیة)<br />- إذا كان لدیك إصابة في الرأس منذ أقل من یوم<br />عندما یتم إعطاء ھذا الدواء سیأخذ طبیبك عینات من الدم والبول لمراقبة:<br />- كمیة المواد الكیمیائیة مثل الصودیوم والبوتاسیوم في دمك.<br />- كمیة السكر في دمك.</p><p>- حموضة دمك وبولك.<br />على الرغم من أن مركب كلورید الصودیوم لاكتیت یحتوي على البوتاسیوم ، إلا أنھ لا یحتوي على ما یكفي لعلاج<br />مستویات بلازما الدم منخفضة للغایة من البوتاسیوم (نقص البوتاسیوم الحاد).<br />طریقة الاعطاء:<br />كلورید الكالسیوم یمكن أن یكون ضارا إذا حقن في أنسجة الجسم, لذلك لا یجب إعطاء مركب الصودیوم لاكتیت عن<br />طریق حقنھ في العضلات (الحقن العضلي).<br />أیضًا ، سیبذل طبیبك كل جھد ممكن لتجنب ھروب المحلول إلى الأنسجة المحیطة بالورید.<br />لا یجب إعطاء مركب كلورید الصودیوم لاكتیت من خلال نفس الإبرة التي یتم بھا نقل الدم. نظرًا لأن مركب<br />الصودیوم لاكتیت یمكن أن یتلف خلایا الدم الحمراء أو یتسبب في تجمعھا معًا.<br />مركب الصودیوم لاكتبت یحتوي على اللاكتات (مادة موجودة في الجسم) ، فإنھ یمكن أن یجعل دمك قلویًا جدًا.<br />بما أن ٥٪ دكستروز في مركب الصودیوم لاكتیت للتسریب یحتوي على دكستروز (سكر العنب) ، فقد یتسبب ذلك في<br />ارتفاع نسبة السكر في الدم (ارتفاع السكر في الدم). في حالة حدوث ذلك ، سوف یفعل طبیبك التالي:<br />- ضبط سرعة التسریب<br />- أعطاء الأنسولین لخفض مستویات السكر في الدم<br />ھذا مھم بشكل خاص إذا كنت مصابًا بمرض السكري.<br />الأطفال:<br />یجب إعطاء الأطفال عنایة خاصة عند اعطاء ٥٪ دكستروز في مركب الصودیوم لاكتیت للتسریب. یتعرض الموالید<br />الجدد ، خاصةً المولودین قبل الأوان والذین یعانون من انخفاض الوزن عند الولادة ، لخطر متزاید للإصابة بمستویات<br />منخفضة أو عالیة من السكر في الدم (نقص السكر في الدم أو ارتفاع السكر في الدم) ، مما قد یؤدي إلى مضاعفات.<br />سیأخذ طبیبك في الاعتبار إذا كنت تتلقى التغذیة الوریدیة (التغذیة المقدمة عن طریق الحقن في الورید).<br />إذا تم إعطاؤك ٥٪ دكستروز في مركب الصودیوم لاكتیت للتسریب لفترة طویلة ، فسوف تحصل على مصدر إضافي<br />من العناصر الغذائیة.<br />الأدویة الأخرى وھذا المنتج<br />أخبر طبیبك أو ممرضك إذا كنت تتناول ، أو قد اتخذت مؤخرا أو قد تأخذ أي أدویة أخرى. من المھم بشكل خاص أن<br />تخبر طبیبك إذا كنت تأخذ:<br />- سیفتریاكسون (مضاد حیوي) ، لا ینبغي أن یعطى من خلال نفس خط التسریب ، ما لم یتم مسحھ جیدًا.<br />- الجلیكوسیدات القلبیة (أمراض القلب) مثل الدیجیتال أو الدیجوكسین المستخدم لعلاج قصور القلب ، یجب ألا<br />تستخدمھ مع ٥٪ دكستروز في مركب الصودیوم لاكتیت. (انظر أیضًا القسم &quot;یجب ألا تتلقى ٥٪ دكستروز في مركب<br />الصودیوم لاكتیت للتسریب إذا كنت تعاني من ...&quot;).<br />یمكن تزید آثار ھذه الأدویة عن طریق الكالسیوم الذي یمكن أن یؤدي إلى تغییرات تھدد الحیاة على إیقاع القلب.<br />- الستیرویدات (الأدویة المضادة للالتھابات)<br />یمكن أن تسبب ھذه الأدویة في تراكم الجسم للصودیوم والماء ، مما یؤدي إلى:<br />- تورم الأنسجة بسبب تجمع السوائل تحت الجلد (وذمة)<br />- ارتفاع ضغط الدم (ارتفاع ضغط الدم).<br />الأدویة التالیة یمكن أن تزید من تركیز البوتاسیوم في الدم. ھذا التأثیر یمكن أن یھدد الحیاة من المرجح أن یحدث<br />ارتفاع في مستویات البوتاسیوم في الدم إذا كان لدیك مرض في الكلى:<br />- مدرات البول الموفرة للبوتاسیوم على سبیل المثال (الأمیلوراید ، سبیرونولاكتون ، تریامتیرین) (لاحظ أن ھذه<br />الأدویة یمكن ان تستخدم مع ادویة اخرى).<br />- مثبطات الإنزیم المحول للأنجیوتنسین (یستخدم لعلاج ارتفاع ضغط الدم).<br />- مضادات مستقبلات أنجیوتنسین (تستخدم لعلاج ارتفاع ضغط الدم).<br />یستخدم لمنع رفض عملیة زرع ومعالجة بعض الأمراض الجلدیة. ( Tacrolimus) - تاكرومیلس<br />- السیكلوسبورین (یستخدم لمنع رفض عملیة الزرع).</p><p>الأدویة الأخرى التي یمكن أن تؤثر أو تتأثر في ٥٪ دكستروز في مركب الصودیوم لاكتیت تتضمن:<br />- مدرات البول الثیازیدیة مثل ھیدروكلوروثیازید أو كلورتالیدون<br />- فیتامین د<br />- البایفوسفونیت (لعلاج أمراض العظام مثل ھشاشة العظام)<br />- الفلورید (للأسنان والعظام)<br />- الفلوروكینولونات (نوع من المضادات الحیویة ، بما في ذلك سیبروفلوكساسین ، نورفلوكساسین ، أوفلوكساسین)<br />- التتراسیكلین (نوع من المضادات الحیویة ، بما في ذلك التتراسیكلین)<br />- الأدویة الحمضیة ، بما في ذلك:<br />- السالیسیلات المستخدمة لعلاج الالتھابات (الأسبرین)<br />- الباربیتورات (أقراص النوم)<br />- اللیثیوم (یستخدم لعلاج الأمراض النفسیة)<br />- الأدویة القلویة (الأساسیة) بما في ذلك:<br />- الأدویة المنشطة مثل الإیفیدرین والسودوإیفیدرین (المستخدمة في المستحضرات السعال والبرد)<br />- المنشطات الأخرى (مثل الدیكسامفیتامین ، الفینفلورامین).<br />٥٪ دكستروز في مركب الصودیوم لاكتیت مع الطعام والشراب<br />یجب أن تسأل طبیبك أو الممرض عما یمكنك أن تأكلھ أو تشربھ.<br />الحمل والرضاعة الطبیعیة<br />إذا كنتِ حاملًا او تعتقدین أنك قد تكوني حاملًا أو تخططي لإنجاب طفل ، اطلبي من طبیبك أو ممرضك الحصول على<br />المشورة قبل تناول ھذا الدواء. یمكن استخدا ٥٪ دكستروز في مركب الصودیوم لاكتیت بأمان أثناء الحمل أو<br />الرضاعة الطبیعیة.<br />سیقوم طبیبك بمراقبة مستویات المواد الكیمیائیة في دمك وكمیة السائل في جسمك.<br />یمكن أن یصل الكالسیوم إلى طفلك الذي لم یولد بعد من خلال المشیمة ، وبعد الولادة أو من خلال حلیب الثدي.<br />ومع ذلك ، إذا تم إضافة دواء آخر إلى محلولك للتسریب أثناء الحمل أو الرضاعة الطبیعیة ، یجب علیك:<br />- استشر طبیبك أو الممرض.<br />- اقرأ نشرة الدواء المراد إضافتھ.<br />القیادة واستخدام الآلات<br />اسأل طبیبك أو الصیدلي للحصول على المشورة قبل القیادة أو استخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>سیتم إعطاؤك ٥٪ دكستروز في مركب الصودیوم للتسریب من قبل الطبیب أو الممرضة<br />سیقرر طبیبك مقدار ما تحتاجھ ومتى یتم إعطاؤه.<br />ھذا یعتمد على عمرك والوزن والحالة وسبب العلاج. قد تتأثر الكمیة الذي قدمت لك أیضًا بالمعالجات الأخرى التي تتلقاھا.<br />یجب ألا یتم إعطاؤك ٥٪ دكستروز في مركب الصودیوم لاكتیت للتسریب إذا كانت ھناك جزیئات تطفو في لمحلول أو<br />في حالة تلف العبوة بأي طریقة.<br />٥٪ دكستروز في مركب الصودیوم لاكتیت للتسریب عادة ما یعطى لك من خلال أنبوب بلاستیكي متصل بإبرة في الورید.<br />عادة ما یتم استخدام الورید في ذراعك لإعطائك الحقن في الورید. ومع ذلك قد یستخدم الطبیب طریقة أخرى لإعطائك الدواء.<br />یجب التخلص من أي محلول غیر مستخدم. یجب أن لا تحصل على اي جرعة من ٥٪ دكستروز في مركب الصودیوم</p><p>لاكتیت من العبوة التي تم استخدامھا جزئیا.<br />إذا كنت تتلقى ٥٪ دكستروز في مركب الصودیوم لاكتیت للتسریب أكثر من مما ینبغي<br />إذا تم إعطاؤك نسبة ٥٪ دكستروز في مركب الصودیوم لاكتیت من أجل التسریب (الإفراط في التسریب) أو إذا تم<br />إعطاؤھا بسرعة كبیرة ، فقد یؤدي ذلك إلى الأعراض التالیة:<br />- زیادة بالماء و / أو الصودیوم (الملح) مع تراكم السائل في الأنسجة (وذمة) مما تسبب تورم.<br />- فرط بوتاسیوم الدم (مستویات البوتاسیوم في الدم أعلى من المعتاد) وخاصة في المرضى الذین یعانون من الفشل<br />الكلوي ، مسببة أعراض مثل:<br />- دبابیس وإبر في الذراعین والساقین (تشوش الحس)<br />- ضعف العضلات<br />- عدم القدرة على الحركة (الشلل)<br />- عدم انتظام ضربات القلب (عدم انتظام ضربات القلب)<br />- كتلة القلب (نبضات بطیئة جدا)<br />- السكتة القلبیة (توقف القلب عن الخفقان ؛ وضع یھدد الحیاة)<br />- الارتباك<br />- فرط كالسیوم الدم (مستویات الكالسیوم في الدم أعلى من المعتاد) مسببة أعراض مثل:<br />- انخفاض الشھیة (فقدان الشھیة)<br />- الشعور بالمرض (غثیان)<br />- القيء<br />- الإمساك<br />- وجع بطن<br />- الاضطرابات العقلیة مثل التھیج أو الاكتئاب<br />(polydipsia) - شرب الكثیر من الماء<br />- إنتاج كمیة أكبر من البول عن المعتاد (بولوریا)<br />- مرض الكلى بسبب تراكم الكالسیوم في الكلى (الكلویة)<br />- حصى الكلى<br />- غیبوبة (فاقد الوعي)<br />- طعم طباشیري<br />- احمرار (الھبات الساخنة)<br />- توسع الأوعیة الدمویة في الجلد (توسع الأوعیة المحیطیة).</p><p>- نقص بوتاسیوم الدم (انخفاض مستویات البوتاسیوم في الدم عن المعدل الطبیعي) والقلویات الأیضیة (عندما یصبح<br />الدم أساسیًا جدًا) خاصة في المرضى الذین یعانون من قصور كلوي ، مما یسبب أعراضًا مثل:<br />- تغیرات في المزاج<br />- التعب<br />- ضیق في التنفس<br />- تصلب العضلات<br />- الوخز في العضلات<br />- تقلص العضلات.<br />- یصبح الدم مركّزًا جدًا (مفرط التناسلیة)<br />- فقدان الماء من الجسم (الجفاف)<br />- ارتفاع مستوى السكر في الدم (ارتفاع السكر في الدم)<br />- السكر في البول (ارتفاع السكر في البول)<br />- زیادة في كمیة البول التي تنتجھا (إدرار البول الأسموزي)<br />إذا ظھرت علیك أي من ھذه الأعراض ، فعلیك إبلاغ طبیبك على الفور. سیتم إیقاف ضخك وسیتم إعطاؤك العلاج<br />وفقًا للأعراض.<br />إذا تمت إضافة دواء إلى ٥٪ دكستروز في مركب الصودیوم لاكتیت للتسریب فقد یتسبب ھذا الدواء أیضًا في ظھور أعراض.<br />یجب علیك قراءة النشرة الطبیة المضافة للحصول على قائمة بالأعراض المحتملة.<br />التوقف عن اعطاء ٥٪ دكستروز في مركب الصودیوم لاكتیت للتسریب<br />سیقرر طبیبك موعد التوقف عن إعطائك المحلول. إذا كانت لدیك أي أسئلة أخرى حول استخدام ھذا المنتج ، اسأل<br />طبیبك أو ممرضتك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جمیع الأدویة ، یمكن أن یسبب ھذا الدواء آثارًا جانبیة ، على الرغم من عدم حصول الجمیع علیھا.<br />إذا كان لدیك أي من الأعراض التالیة ، یجب علیك إخبار طبیبك أو ممرضتك على الفور. قد تكون ھذه علامات على<br />تفاعل شدید الحساسیة أو قاتل للغایة (الحساسیة) یسمى صدمة الحساسیة:<br />- الشرى التي یمكن أن تتحول إلى جزء من الجسم أو على نطاق واسع<br />- الطفح الجلدي<br />- احمرار الجلد (حمامي)<br />- الحكة (الحكة)<br />- تورم الجلد (وذمة وعائیة)<br />- ضیق الشعب الھوائیة یسبب صعوبة في التنفس (تشنج قصبي)<br />- ألم في الصدر أو ألم<br />- ضیق التنفس (ضیق التنفس)<br />- الحمى (بیركسیا)</p><p>- غثیان<br />- السعال<br />قد تكون بعض ردود الفعل بسبب أسلوب اعطاء المحلول بالورید:<br />- طفح أو حكة (حكة) من موقع التسریب<br />- ألم أو تفاعل موضعي (احمرار أو تورم في موضع التسریب)<br />- التخدیر موقع التخدیر (خدر)<br />الآثار الجانبیة الأخرى التي لوحظت مع المنتجات المماثلة (المحالیل الأخرى التي تحتوي على لاكتات الصودیوم) تشمل:<br />المظاھر الأخرى لفرط الحساسیة / تفاعلات التسریب:<br />وذمة الحنجرة (وذمة كوینك) ، ضربات القلب البطیئة (بطء القلب) ، ضربات القلب السریعة<br />(عدم انتظام دقات القلب) ، انخفاض ضغط الدم ، ضائقة التنفس ، الإحمرار ، تھیج الحلق ، تھیج الجلد ، الدبابیس<br />والإبر ، انخفاض الإحساس في الفم (نقص إفرازات الفم) ، تغییر الذوق (عسر الھضم)<br />&bull;القلق<br />&bull;صداع الراس،<br />&bull;إحتقان بالأنف،<br />&bull; العطس<br />&bull; التغیرات في تركیزات المواد الكیمیائیة في الدم (اضطرابات بالاملاح)<br />&bull; ارتفاع مستویات البوتاسیوم في الدم عن المعدل الطبیعي (فرط بوتاسیوم الدم)<br />&bull; وجود كمیة أكبر من الدم في الأوعیة الدمویة مما یجب أن یكون (فرط حجم الدم)<br />&bull; نوبة الھلع<br />&bull; تفاعلات موقع الحقن الأخرى: العدوى في موقع الحقن ، التھاب الورید ، التسرب ، التھاب موضع الحقن ، تورم</p><p>موقع الحقن ، طفح موقع الحقن ، ألم في موقع الحقن ، حرق موقع الحقن.<br />إذا تمت إضافة دواء إلى محلول التسریب ، فقد یتسبب الدواء المضاف أیضًا في حدوث آثار جانبیة. تعتمد ھذه الآثار<br />الجانبیة على الدواء الذي تمت إضافتھ. یجب علیك قراءة نشرة معلومات المریض الخاصة بالدواء المُضاف للحصول<br />على قائمة بالأعراض المحتملة.<br />الإبلاغ عن الآثار الجانبیة<br />إذا كنت تعاني من أي آثار جانبیة ، فتحدث إلى طبیبك أو الصیدلي أو الممرض. یتضمن ذلك أي آثار جانبیة محتملة<br />غیر مدرجة في ھذه النشرة. یمكنك أیضًا الإبلاغ عن الآثار الجانبیة مباشرةً عبر نظام التقاریر الوطني الوارد أدناه.<br />عن طریق الإبلاغ عن الآثار الجانبیة ، یمكنك المساعدة في توفیر المزید من المعلومات حول سلامة ھذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>الحفاظ على ھذا الدواء بعیدا عن متناول الأطفال.<br />أحفظ في درجة حرارة أقل من ۲٥ درجة مئویة.<br />یشیر .(EXP: MM / YYYY : یجب عدم إعطاؤك ھذا الدواء بعد تاریخ انتھاء الصلاحیة المذكور في الكیس (مثال<br />تاریخ انتھاء الصلاحیة إلى الیوم الأخیر من ذلك الشھر. یجب عدم إعطائك ھذا الدواء ، إذا كانت ھناك جسیمات تطفو<br />في المحلول أو إذا تعرضت الوحدة للتلف بأي طریقة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المواد الفعالة ھي: - سكر الدكستروز<br />- كلورید الصودیوم<br />- كلورید البوتاسیوم<br />- كلورید الكالسیوم.<br />- اكتات الصودیوم<br />العنصر الوحید الآخر ھو الماء للحقن</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>٥٪ دكستروز في مركب الصودیوم لاكتیت للتسریب ھو محلول واضح ، خالي من الجزیئات المرئیة<br />یتم توفیره في أكیاس بلاستیكیة.<br />الاحجام المتوفرة ھي: ٥۰۰ مل و ۱۰۰۰ مل</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>مصنع المحالیل الطبیة.<br />العنوان:المنطقة الصناعیة، المرحلة الثانیة.<br />طریق رقم ۲۰۸ ، شارع ۲۰۳<br />. صندوق برید ۱۷٤۷٦ جدة ۲۱٤۸٤<br />المنطقة الغربیة<br />المملكة العربیة السعودیة<br />+۹٦٦-۱۲- الھاتف: ٦۳٦۱۳۸۳<br />+۹٦٦-۱۲- الفاكس: ٦۳۷۹٤٦۰<br />http://www.psiltd.com: الموقع الالكترو</p><p>&nbsp;</p><p>للإبلاغ عن أي أعراض جانبیة:<br />معلومات المریض<br />محلول للحقن بالتسریب الوریدى ف.ب.<br />5% وزن/حجم دكستروز في مركب الصودیوم لاكتیت<br />المملكة العربیة السعودیة<br />المركز الوطني للتیقظ الدوائي:<br />+ فاكس: ۹٦٦۱۱۲۰٥۷٦٦۲<br />مركز الإتصال الموحد لھیئة الغذاء والدواء -السعودیة : ۱۹۹۹۹<br />npc.drug@sfda.gov.sa البرید الإلكتروني<br />https://ade.sfda.gov.sa: الموقع الإلكتروني<br />دول الخلیج الأخرى:<br />الرجاء الاتصال بالمؤسسات والھیئات الوطنیة في كل دولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            03.05.2021
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                5% Dextrose w/v with Compound Sodium Lactate Solution for Infusion.
(Synonym: “Ringer Lactate & Dextrose 5% w/v solution for infusion”)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One liter contains:
Dextrose Monohydrate……………….55 g
Sodium Lactate………………………..3.20 g
Sodium Chloride………………….…..6.00 g
Potassium Chloride……………….…0.40 g
Calcium Chloride 2H2O……..…… 0.27 g
Water for injections……………… 1000 ml
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
clear colorless or faintly straw-colored solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5% Dextrose w/v with Compound Sodium Lactate (Ringer Lactate &amp; Dextrose<br />5% w/v solution) is used in the following indications when a source of<br />carbohydrate is required: - Restoration of extracellular fluid and electrolyte balance<br />or replacement of extracellular fluid loss where isotonic concentrations of<br />electrolytes are sufficient<br />- Short term volume replacement (alone or in association with colloid) in case of<br />hypovolemia or hypotension. - Regulation or maintenance of metabolic acidosis<br />balance and/or treatment of mild to moderate metabolic acidosis (except lactic<br />acidosis)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Adults and the Elderly<br />Dosage, rate, and duration of administration are to be individualized and depend<br />upon the indication for use, the patient&rsquo;s age, weight, clinical condition, and<br />concomitant treatment, and on the patient&rsquo;s clinical and laboratory response to<br />treatment. It should be determined by a physician experienced in intravenous fluid<br />therapy.<br />Recommended dosage: The amount of 5% Dextrose w/v solution with Compound<br />Sodium Lactate needed to restore normal blood volume is 3 to 5 times the volume<br />of lost blood.<br />The recommended dosage is:<br />&bull; for adults: 500 ml to 3Liters /24h<br />&bull; for infants, toddlers and children :<br />&bull; 0-10 kg body weight: 100 ml / kg / 24 h<br />&bull; 10-20 kg body weight: 1000 ml + (50 ml/ kg over 10 kg) / 24h<br />&bull; &gt; 20 kg body weight: 1500 ml + (20 ml/ kg over 20 kg) / 24h.<br />Administration rate: The infusion rate is usually 40 mL/kg/24h in adults.<br />Paediatric patients The safety and efficacy of 5% Dextrose w/v solution with<br />Compound Sodium Lactate in children has not been established by adequate and<br />well-controlled trials; however, the use of electrolyte solutions in the paediatric<br />population is referenced in the medical literature.<br />The infusion rate and volume depends on the age, weight, clinical and metabolic<br />conditions of the patient, concomitant therapy and should be determined by the<br />consulting physician experienced in pediatric intravenous fluid therapy<br />Lactate-containing solutions should be administered with particular caution to<br />neonates and infants less than 6 months of age.</p><p>Pediatric infusion rate is 5 ml/kg/h in average but the value varies with age: &bull;<br />infants: 6-8 mL/kg/h &bull; toddlers: , 4-6 mL/kg/h,<br />&bull; Children: 2-4 mL/kg/h.</p><p>In children with burns, the dose is on average 3.4 mL/kg/per cent burn at 24 h postburn<br />and 6.3 mL/kg/per cent burn at 48 h. In severely head-injured children the<br />dose is on average 2850 mL/m&sup2;.<br />Infusion rate and total volume can be higher in surgery or in case of need.<br />The infusion rate of intravenous solutions containing Dextrose should be selected<br />with caution in children. It should not exceed the patient&rsquo;s ability to utilize<br />Dextrose in order to avoid hyperglycaemia. Therefore the maximum acute<br />administration rate ranges from 5mg/kg/min for adults to 10-18 mg/kg/min for<br />babies and children, depending on the age and the total body mass. See also section<br />4.4, Paediatric population.<br />Note: - infants and toddlers: aged from 28 days to 23 months (a toddler is an infant<br />who can walk)<br />- Children: age from about 2 to 11 years<br />Use in geriatric patients<br />When selecting the type of infusion solution and the volume/rate of infusion for a<br />geriatric patient, consider that geriatric patients are generally more likely to have<br />cardiac, renal, hepatic, and other diseases or concomitant drug therapy.<br />Method of administration:</p><p>The solution is for intravenous administration through a sterile and non-pyrogenic<br />administration set using aseptic technique. The equipment should be primed with<br />the solution in order to prevent air entering the system.<br />The solution should be inspected visually for particulate matter and discoloration<br />prior to administration. Do not administer unless the solution is clear, free from<br />visible particles and the seal is intact. Do not remove unit from overwrap until<br />ready for use. The inner bag maintains the sterility of the solution. Administer<br />immediately following the insertion of infusion set.<br />Do not connect flexible plastic containers in series in order to avoid air embolism<br />due to possible residual air contained in the primary container. Pressurizing<br />intravenous solutions contained in flexible plastic containers to increase flow rates<br />can result in air embolism if the residual air in the container is not fully evacuated<br />prior to administration.</p><p>Use of a vented intravenous administration set with the vent in the open position<br />could result in air embolism. Vented intravenous administration sets with the vent<br />in the open position should not be used with flexible plastic containers.<br />This hypertonic solution should be administered via a large peripheral or<br />preferably a central vein. Rapid infusion in peripheral veins may be harmful.<br />Additives may be introduced before infusion or during infusion through the<br />injection site. When making additions to 5% Dextrose w/v solution with<br />Compound Sodium Lactate, aseptic technique must be used. Mix the solution<br />thoroughly when additives have been introduced. Do not store solutions containing<br />additives.<br />For information on incompatibilities and preparation of the product with additives,<br />please see sections 6.2 and 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                As for other calcium-containing infusion solutions, concomitant administration of
ceftriaxone and 5% Dextrose w/v solution with Compound Sodium Lactate is
contraindicated in newborns (≤ 28 days of age), even if separate infusion lines are
used (risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s
bloodstream). For patients over 28 days of age please see section 4.4.
5% Dextrose w/v solution with Compound Sodium Lactate is also contraindicated
in patients with
• A known hypersensitivity to sodium lactate.
• Extracellular hyperhydration or hypervolemia
• Severe renal insufficiency (with oliguria/anuria)
• Uncompensated cardiac failure
• Hyperkalemia
• Hypercalcaemia
• Metabolic alkalosis
• Ascitic cirrhosis
• Severe metabolic acidosis
• Conditions associated with increased lactate levels (hyperlactatemia) including
lactic acidosis, or impaired lactate utilization, such as severe hepatic insufficiency.
• Concomitant digitalis therapy (see section 4.5 Interactions with other medicinal
products and other forms of interaction)
The solution is also contraindicated in case of uncompensated diabetes, other.
known Dextrose intolerances (such as metabolic stress situations), hyperosmolar.
coma, hyperglycemia, hyperlactatemia
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Hypersensitivity reactions</strong><br />The infusion must be stopped immediately if any signs or symptoms of a suspected<br />hypersensitivity reaction develop. Appropriate therapeutic countermeasures must<br />be instituted as clinically indicated. Solutions containing Dextrose should be used<br />with caution in patients with known allergy to corn or corn products.<br />Incompatibilities<br />Ceftriaxone In patients older than 28 days (including adults), ceftriaxone must not<br />be administered simultaneously with intravenous calcium-containing solutions,<br />including Compound Sodium Lactate &amp; Dextrose 5% solution, through the same<br />infusion line. If the same infusion line is used for sequential administration, the<br />line must be thoroughly flushed between infusions with a compatible fluid. . For<br />patients under 28 days, please see section 4.3.<br />Administration of citrate anticoagulated/preserved blood Due to the risk of<br />coagulation precipitated by its calcium content, 5% Dextrose w/v solution with<br />Compound Sodium Lactate must not be added to or administered simultaneously<br />through the same tubing with citrate anticoagulated/preserved blood.<br />Due to Dextrose presence, 5% Dextrose w/v solution with Compound Sodium<br />Lactate should not be infused concomitantly to massive blood transfusion (risk of<br />pseudo-agglutination) through the same infusion set.<br /><strong>Electrolyte balance</strong><br />Hypernatraemia Compound Sodium Lactate solution should only be administered<br />to patients with hypernatraemia after careful consideration of the underlying cause<br />and alternative intravenous fluids. Monitoring of plasma sodium and volume status<br />during treatment is recommended. Compound Sodium Lactate solution should be</p><p>administered with particular caution in patients with conditions predisposing to<br />hypernatraemia (such as adrenocortical insufficiency, diabetes insipidus or<br />extensive tissue injury) and in patients with cardiac disease.&rdquo;<br />Hyperchloraemia Compound Sodium Lactate solution should only be administered<br />to patients with hyperchloraemia after careful consideration of the underlying<br />cause and alternative intravenous fluids. Monitoring of plasma chloride and acidbase<br />balance during treatment is recommended. Compound Sodium Lactate<br />solution should be administered with particular caution to patients with conditions<br />predisposing to hyperchloraemia (such as renal failure and renal tubular acidosis,<br />diabetes insipidus), and patients with urinary diversion or patients taking certain<br />diuretics (carbonic anhydrase inhibitors e.g. acetazolamide) or steroids (androgens,<br />estrogens corticosteroids) and in patients with severe dehydration<br /><u><strong>Use in patients with potassium deficiency</strong></u><br />Although 5% Dextrose w/v solution with Compound Sodium Lactate has a<br />potassium concentration similar to the concentration in plasma, it is insufficient to<br />produce a useful effect in case of severe potassium insufficiency and therefore it<br />should not be used for this purpose.<br /><u><strong>Use in patients at risk for hyperkalaemia</strong></u><br />5% Dextrose w/v solution with Compound Sodium Lactate should be administered<br />with particular caution to patients with conditions predisposing to hyperkalaemia<br />(such as severe renal impairment or adrenocortical insufficiency, acute<br />dehydration, or extensive tissue injury or burns) and in patients with cardiac<br />disease.<br />The plasma potassium level of the patient must be particularly closely monitored in<br />patients at risk of hyperkalaemia.<br /><u><strong>Use in patients at risk for hypercalcaemia</strong></u><br />Calcium chloride is irritant, therefore care should be taken to prevent extravasation<br />during intravenous injection and intramuscular injection must be avoid</p><p>Solutions containing calcium salts should be used with caution in patients with<br />conditions predisposing to hypercalcaemia, such as patients with renal impairment<br />and granulomatous diseases associated with increased calcitriol synthesis such as<br />sarcoidosis, calcium renal calculi or a history of such calculi fluid balance/renal<br />function.<br />Use in patients with renal impairment<br />5% Dextrose w/v solution with Compound Sodium Lactate should be administered<br />with particular caution to patients with renal impairment. In such patients<br />administration of 5% Dextrose w/v solution with Compound Sodium Lactate may<br />result in sodium and/or potassium retention.<br />Risk of Fluid and/or Solute Overload and Electrolyte Disturbances<br />Depending on the volume and rate of infusion, intravenous administration of 5%<br />Dextrose w/v solution with Compound Sodium Lactate can cause<br />&bull; Fluid and/or solute overload resulting in overhydration and, for example,<br />congested states,including pulmonary congestion and edema.<br />&bull; Clinically relevant electrolyte disturbances and acid-base imbalance.<br />Clinical evaluation and periodic laboratory determinations may be necessary to<br />monitor changes in fluid balance, electrolyte and Dextrose concentrations and acidbase<br />balance during prolonged parenteral therapy or whenever the condition of the<br />patient or the rate of administration warrants such evaluation.<br />High volume infusion must be used under specific monitoring in patients with<br />cardiac or pulmonary failure.<br />Use in patients with hypervolemia, overhydration or conditions causing sodium<br />retention and edema 5% Dextrose w/v solution with Compound Sodium Lactate<br />should be administered with particular caution to hypervolemic or overhydrated<br />patients.<br />Due to the sodium chloride content 5% Dextrose w/v solution with Compound<br />Sodium Lactate should be administered with particular caution to patients with<br />conditions that may cause sodium retention, fluid overload and edema, such as<br />patients with primary hyperaldosteronism, secondary hyperaldosteronism<br />(associated with, e.g., hypertension, congestive heart failure, renal artery stenosis<br />or nephrosclerosis), or preeclampsia. (see also Section Error! Reference source not<br />found.)<br />Acid-base balance Use in patients at risk for alkalosis 5% Dextrose w/v solution<br />with Compound Sodium Lactate should be administered with particular caution to<br />patients at risk for alkalosis. Because lactate is metabolized to bicarbonate</p><p>administration may result in, or worsen, metabolic alkalosis. Seizure may be<br />precipitated by the alkalosis induced by lactate but this is uncommon.<br />Dextrose metabolism Use in patients with or at risk for hyperglycemia Solutions<br />containing Dextrose should be used with caution in patients with impaired<br />Dextrose tolerance or diabetes mellitus. For newborns &ndash; especially those born<br />premature and with low birth weight, please see below &ldquo;use in paediatric patients&rdquo;.<br />Lactate is a substrate for gluconeogenesis. Therefore, Dextrose levels should be<br />carefully monitored in Type 2 diabetics receiving 5% Dextrose w/v solution with<br />Compound Sodium Lactate<br />Because 5% Dextrose w/v solution with Compound Sodium Lactate contains<br />Dextrose and lactate (which is metabolized to Dextrose ), administration of 5%<br />Dextrose w/v solution with Compound Sodium Lactate that exceeds the metabolic<br />capacity for Dextrose may lead to hyperglycaemia.<br />Hyperglycaemia has been implicated in increasing cerebral ischemic brain damage<br />and impairing recovery after acute ischemic strokes. Caution is recommended in<br />using Dextrose containing solutions in such patients.<br />Early hyperglycaemia has been associated with poor outcomes in patients with<br />severe traumatic brain injury. Infusion of Dextrose solution could be<br />contraindicated in the first 24 hours following head trauma and blood Dextrose<br />concentration should be closely monitored during intracranial hypertension<br />episodes.<br />If hyperglycaemia occurs, the rate of administration should be reduced and/or<br />insulin administered, or the insulin dose adjusted<br />Use in paediatric patients<br />Newborns &ndash; especially those born premature and with low birth weight - are at<br />increased risk of developing hypo- or hyperglycaemia and therefore need close<br />monitoring during treatment with intravenous Dextrose solutions to ensure<br />adequate glycaemic control in order to avoid potential long term adverse effects. &bull;</p><p>Hypoglycaemia in the newborn can cause prolonged seizures, coma and brain<br />damage. &bull; Hyperglycaemia has been associated with intraventricular haemorrhage,<br />late onset bacterial and fungal infection, retinopathy of prematurity, necrotizing<br />enterocolitis, bronchopulmonary dysplasia, prolonged length of hospital stay, and<br />death.<br />In order to avoid potentially fatal over infusion of intravenous fluids to the<br />neonate, special attention needs to be paid to the method of administration. When<br />using a syringe pump to administer intravenous fluids or medicines to neonates, a<br />bag of fluid should not be left connected to the syringe. When using an infusion<br />pump all clamps on the intravenous administration set must be closed before<br />removing the administration set from the pump, or switching the pump off. This is<br />required regardless of whether the administration set has an anti-free flow device.<br />The intravenous infusion device and administration equipment must be frequently<br />monitored.<br />Plasma electrolyte concentrations should be closely monitored in the paediatric<br />population as this population may have impaired ability to regulate fluids and<br />electrolytes.<br />Other warnings Osmolarity 5% Dextrose w/v solution with Compound Sodium<br />Lactate is a hypertonic solution, with an approximate osmolarity of 555 mOsm/l.<br />The normal physiologic serum osmolarity range is approximately 280 to 310<br />mOsmol/L.</p><p>Administration of substantially hypertonic solutions may cause venous irritation,<br />including phlebitis. Hyperosmolar solutions should be administered with caution, if<br />at all, to patients with hyperosmolar states.<br />Administration<br />Adding other medication or using an incorrect administration technique might<br />cause the appearance of fever reactions due to the possible introduction of<br />pyrogens. In such case the infusion must be stopped immediately.<br />For information on incompatibilities and preparation of the product with additives,<br />please see sections 6.2 and 6.6.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ceftriaxone: See section 4.3 and 4.4 for more information.<br />Interaction related to the presence of sodium: Caution is advised when<br />administering 5% Dextrose w/v solution with Compound Sodium Lactate to<br />patients treated with drugs that may increase the risk of sodium and fluid retention<br />(with oedema and hypertension), such as corticosteroids.<br />Interaction related to the presence of potassium: Because of its potassium content,<br />5% Dextrose w/v solution with Compound Sodium Lactate should be administered<br />with caution in patients treated with agents or products that can cause<br />hyperkalaemia or increase the risk of hyperkalaemia, such as - Potassium-sparing<br />diuretics (amiloride, spironolactone, triamterene, alone or in association). -<br />Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor<br />antagonists - Tacrolimus, cyclosporin.<br />Administration of potassium in patients treated with such medications can produce<br />severe and potentially fatal hyperkalaemia, particularly in patients with severe<br />renal insufficiency.<br />Interaction related to the presence of calcium: Administration of calcium may<br />increase the effects of digitalis and lead to serious or fatal cardiac arrhythmia.<br />Therefore, larger volumes or a faster infusion rates should be used with caution in<br />patients treated with digitalis glycosides.</p><p>- Caution is advised when administering 5% Dextrose w/v solution with<br />Compound Sodium Lactate to patients treated with thiazide diuretics or vitamin D,<br />as these can increase the risk of hypercalcemia. - Bisphosphonates, fluoride, some<br />fluoroquinolones and tetracyclines which are less absorbed (lower availability)<br />when administered with calcium.<br />Interaction related to the presence of lactate (which is metabolized into<br />bicarbonate):<br />Caution is advised when administering 5% Dextrose w/v solution with Compound<br />Sodium Lactate to patients treated with drugs for which renal elimination is pH<br />dependent. Due to the alkalinizing action of lactate (formation of bicarbonate), 5%<br />Dextrose w/v solution with Compound Sodium Lactate may interfere with the<br />elimination of such drugs. - Renal clearance of acidic drugs such as salicylates,<br />barbiturates, and lithium may be increased because of the alkalinisation of urine by<br />the bicarbonate resulting from lactate metabolism. - Renal clearance of alkaline<br />drugs, such as sympathomimetics (e.g. ephedrine, pseudoephedrine) and stimulants<br />(e.g. dexamphetamine sulfate, phenfluramine hydrochloride) may be decreased</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy 5% Dextrose w/v solution with Compound Sodium Lactate can be used<br />safely during pregnancy and lactation as long as the electrolyte- and fluid balance<br />is controlled<br />Breast-feeding It is reminded that calcium crosses the placenta and is distributed<br />into breast milk.<br />Additions When a medication is added, the nature of the drug and its use during<br />pregnancy and lactation have to be considered separately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies have been conducted on the influence of 5% Dextrose w/v solution with<br />Compound Sodium Lactate on the ability to operate an automobile or other heavy<br />machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following adverse reactions (listed by MedDRA System Organ Class) have<br />been reported spontaneously during the post-market experience. The frequency<br />cannot be estimated from the available data.</p><table border="1" cellspacing="1" cellpadding="1" style="width:100%"><tbody><tr><td style="width:244px">System Organ Class<br />(SOC)</td><td style="width:283px">Adverse reactions (Preferred<br />Term)</td><td style="width:363px">Frequency category</td></tr><tr><td style="width:244px">Immune System<br />Disorders</td><td style="width:283px">Hypersensitivity/infusion<br />reactions, including<br />Anaphylactic/Anaphylactoid<br />reactions, possibly<br />manifested by one or more<br />of the following symptoms:<br />Angioedema, Chest pain,<br />Chest discomfort,<br />Bronchospasm, Dyspnea,<br />Cough, Urticaria, Rash,<br />Pruritus, Erythema, Nausea,<br />Pyrexia,</td><td style="width:363px">Not known</td></tr><tr><td style="width:244px">General Disorders and<br />Administration Site<br />Conditions</td><td style="width:283px">Infusion site reactions<br />possibly manifested by one<br />or more of the following<br />symptoms: Infusion site<br />pruritus, Infusion site<br />erythema, Infusion site<br />anaesthesia(numbness)</td><td style="width:363px">Not known</td></tr></tbody></table><p>The following adverse reactions have been reported spontaneously during the use<br />of other sodium-lactate containing solutions<br />&bull; Other manifestations of hypersensitivity/infusion reactions: Laryngeal edema<br />(Quincke&rsquo;s edema), Bradycardia, Tachycardia, Blood pressure decreased,<br />Respiratory distress, Flushing, Throat irritation, Skin swelling, Paraesthesia,<br />Hypoesthesia oral, Dysgeusia, Anxiety, Headache, Nasal congestion, Sneezing<br />&bull; Electrolyte disturbances<br />&bull; Hyperkalaemia<br />&bull; Hypervolemia<br />&bull; Panic Attack<br />Other infusion site reaction symptoms: Infection at the site of injection, Phlebitis,<br />Extravasation, Infusion site inflammation, Infusion site swelling, Infusion site rash,<br />Infusion site pain, Infusion site burning<br />Reporting of suspected adverse reactions Reporting suspected adverse reactions<br />after authorisation of the medicinal product is important. It allows continued<br />monitoring of the benefit/risk balance of the medicinal product.<br />To report any side effect(s):<br />Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc</p><p>Other GCC States:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>An excessive volume or too high a rate of administration of 5% Dextrose w/v<br />solution with Compound Sodium Lactate may lead to fluid and sodium overload<br />with a risk of edema (peripheral and/or pulmonary), particularly when renal<br />sodium excretion is impaired. In this case extra renal dialysis may be necessary.<br />Excessive administration of potassium may lead to the development of<br />hyperkalemia, especially in patients with renal impairment. Symptoms include<br />paresthesia of the extremities, muscle weakness, paralysis, cardiac arrhythmias,<br />heart block, cardiac arrest, and mental confusion.<br />Excessive administration of calcium salts may lead to hypercalcemia. Symptoms of<br />hypercalcemia may include anorexia, nausea, vomiting, constipation, abdominal<br />pain, muscle weakness, mental disturbances, polydipsia, polyuria,<br />nephrocalcinosis, renal calculi, and, in severe cases, cardiac arrhythmias and coma.<br />Too rapid intravenous injection of calcium salts may also lead to many of the<br />symptoms of hypercalcemia as well as to chalky taste, hot flushes, and peripheral<br />vasodilatation. Mild asymptomatic hypercalcemia will usually resolve on stopping<br />administration of calcium and other contributory drugs such as vitamin D. If<br />hypercalcemia is severe, urgent treatment (such as loop diuretics, hemodialysis,<br />calcitonin, bisphosphonates, trisodium edetate) is required.<br />Excessive administration of lactate may lead to metabolic alkalosis. Metabolic<br />alkalosis may be accompanied by hypokalemia. Symptoms may include mood</p><p>changes, tiredness, shortness of breath, muscle weakness, and irregular heartbeat.<br />Muscle hypertonicity, twitching, and tetany may develop especially in<br />hypocalcemic patients. Treatment of metabolic alkalosis due to bicarbonate<br />overdose consists mainly of appropriate correction of fluid and electrolyte balance.<br />Replacement of calcium, chloride, and potassium may be of particular importance.<br />Excessive administration of a Dextrose -containing solution may lead to<br />hyperglycemia, hyperosmolarity, osmotic diuresis, and dehydration.<br />When overdose is related to medications added to the solution infused, the signs<br />and symptoms of over infusion will be related to the nature of the additive being<br />used. In the event of accidental over infusion, treatment should be discontinued<br />and the patient should be observed for the appropriate signs and symptoms related<br />to the drug administered. The relevant symptomatic and supportive measures<br />should be provided as necessary</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group (ATC code): B05BB02 &ldquo;Electrolytes with<br />Carbohydrates&rdquo;.<br />5% Dextrose w/v solution with Compound Sodium Lactate (Ringer Lactate &amp;<br />Dextrose 5% w/v solution) is an hypertonic solution of electrolytes and Dextrose .<br />The pharmacological properties of the 5% Dextrose w/v solution with Compound<br />Sodium Lactate (Ringer Lactate &amp; Dextrose 5% w/v solution) are those of its<br />components (Dextrose, sodium, potassium, calcium, chloride and lactate).<br />Dextrose is the main source of energy, and this solution provides 200 kcal/L.<br />The main effect of 5% Dextrose w/v solution with Compound Sodium Lactate<br />(Ringer Lactate &amp; Dextrose 5% w/v) is the expansion of the extracellular<br />compartment including both the interstitial fluid and the intravascular fluid.<br />The lactate is metabolised into bicarbonate, mainly in the liver, and produces an<br />alkalinising effect on the plasma.<br />In healthy volunteers receiving Compound Sodium Lactate (Ringer Lactate),<br />central venous pressure changes were associated with a secretion of atrial<br />natriuretic peptide.<br />There is no significant changes in glucagon, norepinephrine, epinephrine, blood<br />Dextrose and insulin levels in aortic surgery patients receiving Compound Sodium<br />Lactate &amp; Dextrose 5% w/v (Ringer Lactate &amp; Dextrose 5% w/v).<br />When medication is added to 5% Dextrose w/v solution with Compound Sodium<br />Lactate (Ringer Lactate &amp; Dextrose 5% w/v), the overall pharmacodynamics of the<br />solution will depend on the nature of the drug used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetic properties of the 5% Dextrose w/v solution with Compound<br />Sodium Lactate (Ringer Lactate &amp; Dextrose 5% w/v solution) are those of its<br />components (Dextrose, sodium, potassium, calcium, chloride and lactate).<br />Infusion of 5% Dextrose w/v solution with Compound Sodium Lactate (Ringer<br />Lactate &amp; Dextrose 5% w/v) in normal hemodynamically stable adults does not<br />increase circulating lactate concentrations.<br />The pharmacokinetics of D-lactate and L-lactate are similar.</p><p>The lactate in Compound Sodium Lactate &amp; Dextrose 5% w/v solution (Ringer<br />Lactate &amp; Dextrose 5% w/v solution) is metabolized by both oxidation and<br />gluconeogenesis, predominantly in the liver, and bicarbonate is generated by both<br />processes over 1-2 h.<br />When medication is added to 5% Dextrose w/v solution with Compound Sodium<br />Lactate (Ringer Lactate &amp; Dextrose 5% w/v), the overall pharmacokinetics of the<br />solution will depend on the nature of the drug used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical safety data of 5% Dextrose w/v solution with Compound Sodium<br />Lactate (Ringer Lactate &amp; Dextrose 5% w/v) solution in animals are not relevant<br />since its constituents are physiological components in animal and human plasma.<br />Toxic effects are not to be expected under the condition of clinical application.<br />The safety of potential additives should be considered separately</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Water for Injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ceftriaxone must not be mixed with calcium-containing solutions including 5%<br />Dextrose w/v solution with Compound Sodium Lactate. See also sections 4.3 and<br />4.4.<br />As with all parenteral solutions additives may be incompatible. Compatibility of<br />the additives with the Compound Sodium Lactate &amp; Dextrose 5% solution and<br />Viaflo container must be assessed before addition. After addition of an additive,<br />check for a possible colour change and/or the appearance of precipitates, insoluble<br />complexes or crystals.<br />The Instructions for Use of the medication to be added and other relevant literature<br />must be consulted.<br />Before adding a substance or medication, verify that it is soluble and/or stable in<br />water and that the pH range of 5% Dextrose w/v solution with Compound Sodium<br />Lactate is appropriate.(pH 4.0 to</p><p>When making additions to 5% Dextrose w/v solution with Compound Sodium<br />Lactate, aseptic technique must be used. Mix the solution thoroughly when<br />additives have been introduced. Do not store solutions containing additives.<br />As guidance the following medications are incompatible with the 5% Dextrose w/v<br />solution with Compound Sodium Lactate (non-exhaustive listing):<br />Medications incompatible with 5% Dextrose w/v solution with Compound Sodium<br />Lactate Aminocaproic acid Amphotericin B Ceftriaxone Cortisone acetate<br />Diethylstilbestrol Etamivan Ethyl alcohol Phosphate and carbonate solutions<br />Oxytetracycline Thiopental sodium Versenate disodium<br />Medications with partial incompatibility with 5% Dextrose w/v solution with<br />Compound Sodium Lactate: Tetracycline stable for 12 hours Ampicillin sodium<br />concentration of 2%-3% stable for 4 hours concentration &gt;3% must be given<br />within 1 hour Minocycline stable for 12 hours Doxycycline stable for 6 hours<br />Additives known or determined to be incompatible should not be used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years for NPVC bags.
4 years for Plastic bottle.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 Co</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The product is a clear, colorless solution in over wrapped Non-PVC Bag with two<br />SFC ports, poly ethylene plastic bottle.<br />NPVC Bag sizes: 1000ml.<br />Plastic bottles sizes: 500 ml and 1000 ml.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After opening the container, the contents should be used immediately and should<br />not be stored for a subsequent infusion.<br />Discard after single use. Discard any unused portion. Do not reconnect partially<br />used bags.</p><p>Return container to in use position, re-open the clamp and continue administration.<br />7. MARKETING AUTHORISATION HOLDER<br />Pharmaceutical Solutions Industry Ltd.<br />Industrial Estate, Phase-2,<br />Road No. 208, Str. - 203<br />P O Box 17476<br />Jeddah 21484<br />Western Province<br />Saudi Arabia<br />Phone: +966-12-6361383<br />FAX: +966-12-6379460<br />Website: http://www.psiltd.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pharmaceutical Solutions Industry
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                July 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>